Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralymphatic Immunotherapy in Allergic Rhinitis
NCT02679105Phase 3Completed
- Sponsor
- Karolinska Institutet
- Start
- May 2015
- Primary completion
- Oct 2016
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of birch allergen extract + grass allergen extract in allergic rhinitis (AR), sponsored by Karolinska Institutet. Started May 2015; status: completed.
02
Drugs
birch allergen extract + grass allergen extract
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT02679105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02679105.